Metastatic Uveal Melanoma Latest Advances

Find the Latest Research About Metastatic Uveal Melanoma

Last Updated: 06/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1512 publications

Correction to: Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.

Correction to: Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.

Journal: The oncologist

Published: March 23, 2026

Current Therapies and Potential Strategies for Uveal Melanoma.

Current Therapies and Potential Strategies for Uveal Melanoma.

Journal: Drugs and drug candidates

Published: February 25, 2026

"BAP1 Loss Induces Senescence and Enhances the Response to Radiation Therapy and Senolytics".

"BAP1 Loss Induces Senescence and Enhances the Response to Radiation Therapy and Senolytics".

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Journal: Journal for immunotherapy of cancer

Published: February 10, 2026

CDK6/4 inactivates BAP1 deubiquitinase destabilizing VHL to promote metastatic colonization in liver.

CDK6/4 inactivates BAP1 deubiquitinase destabilizing VHL to promote metastatic colonization in liver.

Journal: Molecular cancer

Published: February 02, 2026

Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review.

Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review.

Journal: Cancers

Published: January 28, 2026

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State.

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State.

Journal: Investigative ophthalmology & visual science

Published: January 27, 2026

Tebentafusp-associated dermatological adverse events in patients with metastatic uveal melanoma: a single-center retrospective cohort study.

Tebentafusp-associated dermatological adverse events in patients with metastatic uveal melanoma: a single-center retrospective cohort study.

Journal: Melanoma research

Published: January 11, 2026

Rectus Muscle Metastasis from Primary Uveal Melanoma: A Case Series and Literature Review.

Rectus Muscle Metastasis from Primary Uveal Melanoma: A Case Series and Literature Review.

Journal: Ocular oncology and pathology

Published: December 18, 2025

Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.

Commentary: Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis.

Journal: Frontiers in oncology

Published: December 14, 2025

Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma.

Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma.

Journal: Melanoma research

Published: December 14, 2025

Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.

Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.

Journal: Diagnostic and interventional imaging

Published: December 09, 2025

Showing 1-12 of 1,512

Last Updated: 06/24/2026